Other Species / Isoforms
  CBL (mouse)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K7
_MAGNVKKSSGAGGG
0 5
CBL (human) _MAGNVKksSGAGGG K7-ub
CBL (mouse) _MAGNVKKSSGAGGG K7
CBL (rat) _MAGNVKKSSGAGGS K7
S8
MAGNVKKSSGAGGGG
0 1
CBL (human) MAGNVKksSGAGGGs S8-p
CBL (mouse) MAGNVKKSSGAGGGG S8
CBL (rat) MAGNVKKSSGAGGSG S8
-
gap
0 1
CBL (human) sSGAGGGsGsGGsGs S15-p
CBL (mouse) gap -
CBL (rat) KSSGAGGSGSGGSGA S14
S16
SGAGGGGSGGSGAGG
0 2
CBL (human) GAGGGsGsGGsGsGG S17-p
CBL (mouse) SGAGGGGSGGSGAGG S16
CBL (rat) SGAGGSGSGGSGAGG S16
S19
GGGGSGGSGAGGLIG
0 1
CBL (human) GGsGsGGsGsGGLIG S20-p
CBL (mouse) GGGGSGGSGAGGLIG S19
CBL (rat) GGSGSGGSGAGGLIG S19
A21
GGSGGSGAGGLIGLM
0 1
CBL (human) sGsGGsGsGGLIGLM S22-p
CBL (mouse) GGSGGSGAGGLIGLM A21
CBL (rat) SGSGGSGAGGLIGLM A21
K56
VDKKMVEKCWKLMDK
0 1
CBL (human) VDKKMVEkCWKLMDK K58-ub
CBL (mouse) VDKKMVEKCWKLMDK K56
CBL (rat) VDKKMVEKCWKLMDK K57
K72
VRLCQNPKLALKNSP
0 3
CBL (human) VRLCQNPkLALKNSP K74-ub
CBL (mouse) VRLCQNPKLALKNSP K72
CBL (rat) VRLCQNPKLALKNSP K73
K103
VLSRYEGKMETLGEN
0 1
CBL (human) ILSRYEGkMETLGEN K105-ub
CBL (mouse) VLSRYEGKMETLGEN K103
CBL (rat) VLSRYEGKMETLGEN K104
T124
MENLMKKTKQTISLF
0 1
CBL (human) MENLMKKtKQTISLF T126-p
CBL (mouse) MENLMKKTKQTISLF T124
CBL (rat) MENLMKKTKQTISLF T125
K132
KQTISLFKEGKERMY
0 2
CBL (human) KQTISLFkEGKERMy K134-ac
CBL (mouse) KQTISLFKEGKERMY K132
CBL (rat) KQTISLFKEGKERMY K133
Y139
KEGKERMYEENSQPR
0 17
CBL (human) kEGKERMyEENSQPR Y141-p
CBL (mouse) KEGKERMYEENSQPR Y139
CBL (rat) KEGKERMYEENSQPR Y140
K195
WRKAFGEKTIVPWkS
0 1
CBL (human) WRKAFGEkTIVPWkS K197-ac
CBL (mouse) WRKAFGEKTIVPWkS K195
CBL (rat) WRKAFGEKTIVPWKS K196
K201-ub
EKTIVPWkSFRQALH
0 8
CBL (human) EkTIVPWkSFRQALH K203-ub
CBL (mouse) EKTIVPWkSFRQALH K201-ub
CBL (rat) EKTIVPWKSFRQALH K202
Y366
IKVTQEQYELyCEMG
1 5
CBL (human) IKVTQEQyELyCEMG Y368-p
CBL (mouse) IKVTQEQYELyCEMG Y366
CBL (rat) IKVTQEQYELYCEMG Y367
Y369-p
TQEQYELyCEMGSTF
Upstream
Downstream
8 89
Effects on Modified Protein
  • ubiquitination
Effects on Biological Processes:
  • carcinogenesis, inhibited
  • signaling pathway regulation
Putative upstream phosphatases:
  • PTP4A2 (human)
Treatment
  • PRLi
  • siRNA
CBL (human) TQEQyELyCEMGSTF Y371-p
CBL (mouse) TQEQYELyCEMGSTF Y369-p
CBL (rat) TQEQYELYCEMGSTF Y370
K422
PFCRCEIKGTEPIVV
0 7
CBL (human) PFCRCEIkGTEPIVV K424-ub
CBL (mouse) PFCRCEIKGTEPIVV K422
CBL (rat) PFCRCEIKGTEPIVV K423
S437
DPFDPRGSGsLLRQG
0 3
CBL (human) DPFDPRGsGsLLRQG S439-p
CBL (mouse) DPFDPRGSGsLLRQG S437
CBL (rat) DPFDPRGSGSLLRQG S438
S439-p
FDPRGSGsLLRQGAE
0 4
CBL (human) FDPRGsGsLLRQGAE S441-p
CBL (mouse) FDPRGSGsLLRQGAE S439-p
CBL (rat) FDPRGSGSLLRQGAE S440
S450-p
QGAEGAPsPNyDDDD
0 14
CBL (human) QGAEGAPsPNyDDDD S452-p
CBL (mouse) QGAEGAPsPNyDDDD S450-p
CBL (rat) QGAEGAPsPNYDDDD S451-p
Y453-p
EGAPsPNyDDDDDER
Upstream
0 35
Treatment
  • EGF
CBL (human) EGAPsPNyDDDDDER Y455-p
CBL (mouse) EGAPsPNyDDDDDER Y453-p
CBL (rat) EGAPsPNYDDDDDER Y454
S480-p
GAKVERPssPFsMAP
0 4
CBL (human) GAKVERPPsPFsMAP P482
CBL (mouse) GAKVERPssPFsMAP S480-p
CBL (rat) GAKVERPSSPFSMAP S481
S481-p
AKVERPssPFsMAPQ
0 23
CBL (human) AKVERPPsPFsMAPQ S483-p
CBL (mouse) AKVERPssPFsMAPQ S481-p
CBL (rat) AKVERPSSPFSMAPQ S482
S484-p
ERPssPFsMAPQASL
0 13
CBL (human) ERPPsPFsMAPQAsL S486-p
CBL (mouse) ERPssPFsMAPQASL S484-p
CBL (rat) ERPSSPFSMAPQASL S485
S490
FsMAPQASLPPVPPR
0 3
CBL (human) FsMAPQAsLPPVPPR S492-p
CBL (mouse) FsMAPQASLPPVPPR S490
CBL (rat) FSMAPQASLPPVPPR S491
R504
RLDLLQQRAPVPAST
0 3
CBL (human) RLDLLPQRVCVPssA R506
CBL (mouse) RLDLLQQRAPVPAST R504
CBL (rat) RLDLLQQrAPVPAST R505-m1
A509
QQRAPVPASTSVLGT
0 1
CBL (human) PQRVCVPssAsALGT S511-p
CBL (mouse) QQRAPVPASTSVLGT A509
CBL (rat) QQrAPVPASTSVLGT A510
S510
QRAPVPASTSVLGTA
0 1
CBL (human) QRVCVPssAsALGTA S512-p
CBL (mouse) QRAPVPASTSVLGTA S510
CBL (rat) QrAPVPASTSVLGTA S511
S512
APVPASTSVLGTASK
0 1
CBL (human) VCVPssAsALGTAsk S514-p
CBL (mouse) APVPASTSVLGTASK S512
CBL (rat) APVPASTSVLGTASK S513
S518
TSVLGTASKAASGSL
0 1
CBL (human) AsALGTAskAASGSL S520-p
CBL (mouse) TSVLGTASKAASGSL S518
CBL (rat) TSVLGTASKASSSSL S519
K519
SVLGTASKAASGSLH
0 2
CBL (human) sALGTAskAASGSLH K521-ub
CBL (mouse) SVLGTASKAASGSLH K519
CBL (rat) SVLGTASKASSSSLH K520
Y550
PPPPDRPYSVGAETR
0 5
CBL (human) PPPPDRPySVGAESR Y552-p
CBL (mouse) PPPPDRPYSVGAETR Y550
CBL (rat) PPPPDRPYSVGTETR Y551
T566
QRRPLPCTPGDCPSR
0 9
CBL (human) QRRPLPCtPGDCPSR T568-p
CBL (mouse) QRRPLPCTPGDCPSR T566
CBL (rat) QRRPLPCTPGDCPSR T567
K575
GDCPSRDKLPPVPSS
0 2
CBL (human) GDCPSRDkLPPVPss K577-ub
CBL (mouse) GDCPSRDKLPPVPSS K575
CBL (rat) GDCPSRDKLPPVPSS K576
S581
DKLPPVPSSRPGDSW
0 1
CBL (human) DkLPPVPssRLGDsW S583-p
CBL (mouse) DKLPPVPSSRPGDSW S581
CBL (rat) DKLPPVPSSRPGDSW S582
S582
KLPPVPSSRPGDSWL
0 1
CBL (human) kLPPVPssRLGDsWL S584-p
CBL (mouse) KLPPVPSSRPGDSWL S582
CBL (rat) KLPPVPSSRPGDSWL S583
S587
PSSRPGDSWLSRPIP
0 2
CBL (human) PssRLGDsWLPRPIP S589-p
CBL (mouse) PSSRPGDSWLSRPIP S587
CBL (rat) PSSRPGDSWLSRPIP S588
A599
PIPKVPVATPNPGDP
0 2
CBL (human) PIPKVPVsAPSSSDP S601-p
CBL (mouse) PIPKVPVATPNPGDP A599
CBL (rat) PIPKVPVATPNPGDP A600
S617-p
RELTNRHsLPFsLPS
Upstream
1 29
Treatment
  • insulin
  • LY294002
CBL (human) RELTNRHsLPFsLPS S619-p
CBL (mouse) RELTNRHsLPFsLPS S617-p
CBL (rat) RELTNRHSLPFSLPS S618
S621-p
NRHsLPFsLPSQMEP
Upstream
1 3
Treatment
  • insulin
CBL (human) NRHsLPFsLPSQMEP S623-p
CBL (mouse) NRHsLPFsLPSQMEP S621-p
CBL (rat) NRHSLPFSLPSQMEP S622
S637-p
ADVPRLGsTFsLDTS
1 2
CBL (human) PDVPRLGstFsLDts S639-p
CBL (mouse) ADVPRLGsTFsLDTS S637-p
CBL (rat) ADVPRLGSTFSLDTS S638
T638
DVPRLGsTFsLDTSM
1 2
CBL (human) DVPRLGstFsLDtsM T640-p
CBL (mouse) DVPRLGsTFsLDTSM T638
CBL (rat) DVPRLGSTFSLDTST T639
S640-p
PRLGsTFsLDTSMTM
1 11
CBL (human) PRLGstFsLDtsMSM S642-p
CBL (mouse) PRLGsTFsLDTSMTM S640-p
CBL (rat) PRLGSTFSLDTSTTM S641
T643
GsTFsLDTSMTMNSS
0 1
CBL (human) GstFsLDtsMSMNSs T645-p
CBL (mouse) GsTFsLDTSMTMNSS T643
CBL (rat) GSTFSLDTSTTMNSS T644
S644
sTFsLDTSMTMNSSP
0 3
CBL (human) stFsLDtsMSMNSsP S646-p
CBL (mouse) sTFsLDTSMTMNSSP S644
CBL (rat) STFSLDTSTTMNSSP S645
S650
TSMTMNSSPVAGPES
0 1
CBL (human) tsMSMNSsPLVGPEC S652-p
CBL (mouse) TSMTMNSSPVAGPES S650
CBL (rat) TSTTMNSSPVAGPES S651
S665
EHPKIKPSssANAIy
0 26
CBL (human) DHPKIKPsssANAIy S667-p
CBL (mouse) EHPKIKPSssANAIy S665
CBL (rat) EHPKIKPSSSANAIy S666
S666-p
HPKIKPSssANAIys
Upstream
0 18
Regulatory protein:
  • FCER1A (mouse)
CBL (human) HPKIKPsssANAIys S668-p
CBL (mouse) HPKIKPSssANAIys S666-p
CBL (rat) HPKIKPSSSANAIyS S667
S667-p
PKIKPSssANAIysL
Upstream
0 228
Regulatory protein:
  • FCER1A (mouse)
Treatment
  • insulin
  • LY294002
  • MK-2206
CBL (human) PKIKPsssANAIysL S669-p
CBL (mouse) PKIKPSssANAIysL S667-p
CBL (rat) PKIKPSSSANAIySL S668
Y672-p
SssANAIysLAARPL
Upstream
2 739
Regulatory protein:
  • FCER1A (mouse)
CBL (human) sssANAIysLAARPL Y674-p
CBL (mouse) SssANAIysLAARPL Y672-p
CBL (rat) SSSANAIySLAARPL Y673-p
S673-p
ssANAIysLAARPLP
0 110
CBL (human) ssANAIysLAARPLP S675-p
CBL (mouse) ssANAIysLAARPLP S673-p
CBL (rat) SSANAIySLAARPLP S674
S692-p
PPGEQGEsEEDtEyM
Upstream
0 11
Treatment
  • IL-33
CBL (human) PPGEQCEGEEDtEyM G694
CBL (mouse) PPGEQGEsEEDtEyM S692-p
CBL (rat) PPGEQGDsEEDTEyM S693-p
T696-p
QGEsEEDtEyMTPTs
0 26
CBL (human) QCEGEEDtEyMtPss T698-p
CBL (mouse) QGEsEEDtEyMTPTs T696-p
CBL (rat) QGDsEEDTEyMTPTS T697
Y698-p
EsEEDtEyMTPTsRP
Upstream
Downstream
16 509
CBL (human)
Y700-p
CBL (rat)
Y699-p
Effects on Modified Protein
  • ubiquitination
Regulatory protein:
  • Syk (human)
Treatment
  • EGF
  • IL-33
  • insulin
  • PDGF
  • PP2
  • TNP
  • ursolic_acid
  • VEGF
CBL (human) EGEEDtEyMtPssRP Y700-p
CBL (mouse) EsEEDtEyMTPTsRP Y698-p
CBL (rat) DsEEDTEyMTPTSRP Y699-p
T700
EEDtEyMTPTsRPVG
0 13
CBL (human) EEDtEyMtPssRPLR T702-p
CBL (mouse) EEDtEyMTPTsRPVG T700
CBL (rat) EEDTEyMTPTSRPVG T701
T702
DtEyMTPTsRPVGVQ
0 34
CBL (human) DtEyMtPssRPLRPL S704-p
CBL (mouse) DtEyMTPTsRPVGVQ T702
CBL (rat) DTEyMTPTSRPVGVQ T703
S703-p
tEyMTPTsRPVGVQK
0 23
CBL (human) tEyMtPssRPLRPLD S705-p
CBL (mouse) tEyMTPTsRPVGVQK S703-p
CBL (rat) TEyMTPTSRPVGVQK S704
A719
EPKRPLEATQsSRAC
0 1
CBL (human) RPLRPLDtsQssRAC T713-p
CBL (mouse) EPKRPLEATQsSRAC A719
CBL (rat) EPKRPAETAQSSRAC T720
T720
PKRPLEATQsSRACD
0 4
CBL (human) PLRPLDtsQssRACD S714-p
CBL (mouse) PKRPLEATQsSRACD T720
CBL (rat) PKRPAETAQSSRACD A721
S722-p
RPLEATQsSRACDCD
0 5
CBL (human) RPLDtsQssRACDCD S716-p
CBL (mouse) RPLEATQsSRACDCD S722-p
CBL (rat) RPAETAQSSRACDCD S723
S723
PLEATQsSRACDCDQ
0 4
CBL (human) PLDtsQssRACDCDQ S717-p
CBL (mouse) PLEATQsSRACDCDQ S723
CBL (rat) PAETAQSSRACDCDQ S724
Y737-p
QQIDSCTyEAMYNIQ
Upstream
Downstream
17 35
CBL (human)
Y731-p
Effects on Modified Protein
  • molecular association, regulation
  • phosphorylation
  • ubiquitination
Effects on Biological Processes:
  • cytoskeletal reorganization
Putative in vivo kinases:
  • Src (human)
Regulatory protein:
  • CLEC9A (human)
  • Syk (human)
Treatment
  • antibody
  • curdlan
  • PP2
  • TNF
  • VEGF
CBL (human) QQIDSCTyEAMyNIQ Y731-p
CBL (mouse) QQIDSCTyEAMYNIQ Y737-p
CBL (rat) QQIDSCTYEAMYNIQ Y738
Y741
SCTyEAMYNIQSQAL
0 4
CBL (human) SCTyEAMyNIQSQAP Y735-p
CBL (mouse) SCTyEAMYNIQSQAL Y741
CBL (rat) SCTYEAMYNIQSQAL Y742
T768
LATAHTSTGPEEsEN
0 3
CBL (human) LAAAHANtGPEEsEN T762-p
CBL (mouse) LATAHTSTGPEEsEN T768
CBL (rat) LATAHTSTGPEESEN T769
S773-p
TSTGPEEsENEDDGy
0 252
CBL (human) ANtGPEEsENEDDGy S767-p
CBL (mouse) TSTGPEEsENEDDGy S773-p
CBL (rat) TSTGPEESENEDDGY S774
Y780-p
sENEDDGyDVPKPPV
Upstream
Downstream
16 260
CBL (human)
Y774-p
CBL (mouse)
Y780-p
Effects on Modified Protein
  • molecular association, regulation
  • ubiquitination
Effects on Biological Processes:
  • cytoskeletal reorganization
Putative in vivo kinases:
  • Src (human)
Regulatory protein:
  • CLEC9A (human)
  • P38A (mouse)
Treatment
  • anisomycin
  • antibody
  • curdlan
  • EGF
  • SB202190
  • TNF
  • VEGF
CBL (human) sENEDDGyDVPKPPV Y774-p
CBL (mouse) sENEDDGyDVPKPPV Y780-p
CBL (rat) SENEDDGYDVPKPPV Y781
T795-p
PAVLARRtLsDISNA
Upstream
0 8
Treatment
  • IL-33
CBL (human) PAVLARRtLsDIsNA T789-p
CBL (mouse) PAVLARRtLsDISNA T795-p
CBL (rat) PAVLARRTLSDISNA T796
S797-p
VLARRtLsDISNAss
Upstream
0 45
Treatment
  • IL-33
CBL (human) VLARRtLsDIsNAsS S791-p
CBL (mouse) VLARRtLsDISNAss S797-p
CBL (rat) VLARRTLSDISNASS S798
S800
RRtLsDISNAsssFG
0 1
CBL (human) RRtLsDIsNAsSsFG S794-p
CBL (mouse) RRtLsDISNAsssFG S800
CBL (rat) RRTLSDISNASSSFG S801
S803-p
LsDISNAsssFGWLs
0 2
CBL (human) LsDIsNAsSsFGWLs S797-p
CBL (mouse) LsDISNAsssFGWLs S803-p
CBL (rat) LSDISNASSSFGWLS S804
S804-p
sDISNAsssFGWLsL
0 1
CBL (human) sDIsNAsSsFGWLsL S798
CBL (mouse) sDISNAsssFGWLsL S804-p
CBL (rat) SDISNASSSFGWLSL S805
S805-p
DISNAsssFGWLsLD
0 5
CBL (human) DIsNAsSsFGWLsLD S799-p
CBL (mouse) DISNAsssFGWLsLD S805-p
CBL (rat) DISNASSSFGWLSLD S806
S810-p
sssFGWLsLDGDPTN
0 15
CBL (human) sSsFGWLsLDGDPTT S804-p
CBL (mouse) sssFGWLsLDGDPTN S810-p
CBL (rat) SSSFGWLSLDGEPTN S811
S838
PFPRRINSERKASSy
0 12
CBL (human) PFPRRINsERKAGSC S833-p
CBL (mouse) PFPRRINSERKASSy S838
CBL (rat) PFPRRINSERKASSY S839
Y845-p
SERKASSyQQGGGAT
0 30
CBL (human) sERKAGSCQQGSGPA C840
CBL (mouse) SERKASSyQQGGGAT Y845-p
CBL (rat) SERKASSYQQGGGAM Y846
S873
SEIERLMSQGYSYQD
1 1
CBL (human) SEIENLMsQGYSYQD S866-p
CBL (mouse) SEIERLMSQGYSYQD S873
CBL (rat) SEIERLMSQGYSYQD S874
S904-p
NILREFVsISSPAHV
0 1
CBL (human) NILREFVSISsPAHV S897
CBL (mouse) NILREFVsISSPAHV S904-p
CBL (rat) NILREFVSISSPAHV S905
S907
REFVsISSPAHVAT_
0 4
CBL (human) REFVSISsPAHVAT_ S900-p
CBL (mouse) REFVsISSPAHVAT_ S907
CBL (rat) REFVSISSPAHVAT_ S908